Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2011 Sep 10;39(1):138–148. doi: 10.1007/s00259-011-1930-x

Fig. 5.

Fig. 5

Biodistribution studies in 4T1 tumor-bearing mice. a Biodistribution of 89Zr-Df-TRC105 at 24 h post-injection (n = 4). b Biodistribution of 89Zr-Df-TRC105 and 89Zr-Df-TRC105 after a blocking dose of TRC105 at 96 h post-injection (n = 4). c Biodistribution of 89Zr-Df-TRC105 and 89Zr-Df-cetuximab at 96 h post-injection (n = 4). *: P < 0.05; **: P < 0.01.